PURPOSE: We characterize the in vivo changes over time in the retinal structure of wild-type mice alongside two lines of mice deficient in the β-subunit of phosphodiesterase (rd1 and rd10 mice) using spectral domain optical coherence tomography (SD-OCT). METHODS: SD-OCT images were obtained using the Bioptigen spectral domain ophthalmic imaging system (SDOIS). Wild-type C57BL/6J, rd1 and rd10 mice ranging in age from P14 to P206 were sedated with 1% isoflurane. Horizontal and vertical linear scans through the optic nerve, and annular scans around the optic nerve were obtained. RESULTS: SD-OCT imaging of wild-type mice demonstrated visibility of the inner segment/outer segment (IS/OS) junction, external limiting membrane (ELM), outer nuclear layer (ONL), and outer plexiform layer (OPL). At P14, most rd10 mice exhibited normal SD-OCT profiles, but some displayed changes in the IS/OS junction. At the same time point, rd1 mice had severe outer retinal degeneration. In rd10 mice, imaging revealed loss of the IS/OS junction by P18, hyperreflective changes in the ONL at P20, hyperreflective vitreous opacities, and shallow separation of the neural retina from the RPE. Retinal separations were not observed in rd1 mice. Segmentation analysis in wild-type mice demonstrated relatively little variability between animals, while in rd10 and rd1 mice there was a steady decline in outer retinal thickness. Histologic studies demonstrated correlation of retinal features with those seen on SD-OCT scans. Segmentation analysis provides a quantitative and reproducible method for measuring in vivo retinal changes in mice. CONCLUSIONS: SD-OCT provides a non-invasive method of following long-term retinal changes in mice in vivo. Although rd10 and rd1 mice have mutations in the same gene, they demonstrate significantly different features on SD-OCT.
PURPOSE: We characterize the in vivo changes over time in the retinal structure of wild-type mice alongside two lines of mice deficient in the β-subunit of phosphodiesterase (rd1 and rd10mice) using spectral domain optical coherence tomography (SD-OCT). METHODS: SD-OCT images were obtained using the Bioptigen spectral domain ophthalmic imaging system (SDOIS). Wild-type C57BL/6J, rd1 and rd10mice ranging in age from P14 to P206 were sedated with 1% isoflurane. Horizontal and vertical linear scans through the optic nerve, and annular scans around the optic nerve were obtained. RESULTS: SD-OCT imaging of wild-type mice demonstrated visibility of the inner segment/outer segment (IS/OS) junction, external limiting membrane (ELM), outer nuclear layer (ONL), and outer plexiform layer (OPL). At P14, most rd10mice exhibited normal SD-OCT profiles, but some displayed changes in the IS/OS junction. At the same time point, rd1mice had severe outer retinal degeneration. In rd10mice, imaging revealed loss of the IS/OS junction by P18, hyperreflective changes in the ONL at P20, hyperreflective vitreous opacities, and shallow separation of the neural retina from the RPE. Retinal separations were not observed in rd1mice. Segmentation analysis in wild-type mice demonstrated relatively little variability between animals, while in rd10 and rd1mice there was a steady decline in outer retinal thickness. Histologic studies demonstrated correlation of retinal features with those seen on SD-OCT scans. Segmentation analysis provides a quantitative and reproducible method for measuring in vivo retinal changes in mice. CONCLUSIONS: SD-OCT provides a non-invasive method of following long-term retinal changes in mice in vivo. Although rd10 and rd1mice have mutations in the same gene, they demonstrate significantly different features on SD-OCT.
Authors: Elisabeth M Anger; Angelika Unterhuber; Boris Hermann; Harald Sattmann; Christian Schubert; James E Morgan; Alan Cowey; Peter K Ahnelt; Wolfgang Drexler Journal: Exp Eye Res Date: 2004-06 Impact factor: 3.467
Authors: Ji-jing Pang; Xufeng Dai; Shannon E Boye; Ilaria Barone; Sanford L Boye; Song Mao; Drew Everhart; Astra Dinculescu; Li Liu; Yumiko Umino; Bo Lei; Bo Chang; Robert Barlow; Enrica Strettoi; William W Hauswirth Journal: Mol Ther Date: 2010-12-07 Impact factor: 11.454
Authors: B Chang; N L Hawes; M T Pardue; A M German; R E Hurd; M T Davisson; S Nusinowitz; K Rengarajan; A P Boyd; S S Sidney; M J Phillips; R E Stewart; R Chaudhury; J M Nickerson; J R Heckenlively; J H Boatright Journal: Vision Res Date: 2007-01-30 Impact factor: 1.886
Authors: Donald C Hood; Christine E Lin; Margot A Lazow; Kirsten G Locke; Xian Zhang; David G Birch Journal: Invest Ophthalmol Vis Sci Date: 2008-11-14 Impact factor: 4.799
Authors: Ki Hean Kim; Mehron Puoris'haag; Gopi N Maguluri; Yumiko Umino; Karen Cusato; Robert B Barlow; Johannes F de Boer Journal: J Vis Date: 2008-01-24 Impact factor: 2.240
Authors: Marco Ruggeri; Gavriil Tsechpenakis; Shuliang Jiao; Maria Elena Jockovich; Colleen Cebulla; Eleut Hernandez; Timothy G Murray; Carmen A Puliafito Journal: Opt Express Date: 2009-03-02 Impact factor: 3.894
Authors: Bhavna J Antony; Michael D Abràmoff; Matthew M Harper; Woojin Jeong; Elliott H Sohn; Young H Kwon; Randy Kardon; Mona K Garvin Journal: Biomed Opt Express Date: 2013-11-01 Impact factor: 3.732
Authors: Peter D Westenskow; Toshihide Kurihara; Stephen Bravo; Daniel Feitelberg; Zack A Sedillo; Edith Aguilar; Martin Friedlander Journal: J Vis Exp Date: 2015-01-23 Impact factor: 1.355
Authors: Yi Jiang; Xin Qi; Micah A Chrenek; Christopher Gardner; Jeffrey H Boatright; Hans E Grossniklaus; John M Nickerson Journal: Invest Ophthalmol Vis Sci Date: 2013-11-05 Impact factor: 4.799
Authors: Brandon J Lujan; Austin Roorda; Jason A Croskrey; Adam M Dubis; Robert F Cooper; Jan-Kristine Bayabo; Jacque L Duncan; Bhavna J Antony; Joseph Carroll Journal: Retina Date: 2015-08 Impact factor: 4.256
Authors: Brent A Bell; Charles Kaul; Vera L Bonilha; Mary E Rayborn; Karen Shadrach; Joe G Hollyfield Journal: Exp Eye Res Date: 2015-04-18 Impact factor: 3.467